Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Pistorio

Showing results (141-150 of 228) with videos related to

Pageof 23
Sort By:
Arthritis Care & Research|May 28, 2011
Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritisAlessandro Consolaro, Nicolino Ruperto, Angela Pistorio, et al.
Pediatric Rheumatology Online Journal|September 7, 2022
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the "comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS" (STARS) trialMarco Burrone, Marta Mazzoni, Roberta Naddei, et al.
The Journal of Rheumatology|March 3, 2011
A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment ReportGiovanni Filocamo, Alessandro Consolaro, Benedetta Schiappapietra, et al.
Neuro-Oncology|April 14, 2011
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastomaAlessandro Raso, Samantha Mascelli, Roberto Biassoni, et al.
Annals of the Rheumatic Diseases|December 19, 2013
Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity scoreAlessandro Consolaro, Nicolino Ruperto, Giulia Bracciolini, et al.
The Journal of Rheumatology|July 15, 2003
Increased expression of alpha(1,3)-fucosyltransferase-VII and P-selectin binding of synovial fluid T cells in juvenile idiopathic arthritisFabrizio De Benedetti, Patrizia Pignatti, Mauro Biffi, et al.
Pediatric Blood & Cancer|April 26, 2017
Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomesStefano Avanzini, Luca Pio, Giovanni Erminio, et al.
RMD Open|February 2, 2024
Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity IndexSilvia Rosina, Alessandro Consolaro, Angela Pistorio, et al.
British Journal of Haematology|August 26, 2004
Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian populationCarlo Dufour, Mario Capasso, Johanna Svahn, et al.
Arthritis Research & Therapy|September 11, 2020
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trialsClara Malattia, Nicolino Ruperto, Silvia Pederzoli, et al.
Pageof 23

Showing results (141-150 of 228) with videos related to

Sort By:
Pageof 23
Arthritis Care & Research|May 28, 2011
Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritisAlessandro Consolaro, Nicolino Ruperto, Angela Pistorio, et al.
Pediatric Rheumatology Online Journal|September 7, 2022
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the "comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS" (STARS) trialMarco Burrone, Marta Mazzoni, Roberta Naddei, et al.
The Journal of Rheumatology|March 3, 2011
A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment ReportGiovanni Filocamo, Alessandro Consolaro, Benedetta Schiappapietra, et al.
Neuro-Oncology|April 14, 2011
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastomaAlessandro Raso, Samantha Mascelli, Roberto Biassoni, et al.
Annals of the Rheumatic Diseases|December 19, 2013
Defining criteria for high disease activity in juvenile idiopathic arthritis based on the juvenile arthritis disease activity scoreAlessandro Consolaro, Nicolino Ruperto, Giulia Bracciolini, et al.
The Journal of Rheumatology|July 15, 2003
Increased expression of alpha(1,3)-fucosyltransferase-VII and P-selectin binding of synovial fluid T cells in juvenile idiopathic arthritisFabrizio De Benedetti, Patrizia Pignatti, Mauro Biffi, et al.
Pediatric Blood & Cancer|April 26, 2017
Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomesStefano Avanzini, Luca Pio, Giovanni Erminio, et al.
RMD Open|February 2, 2024
Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity IndexSilvia Rosina, Alessandro Consolaro, Angela Pistorio, et al.
British Journal of Haematology|August 26, 2004
Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian populationCarlo Dufour, Mario Capasso, Johanna Svahn, et al.
Arthritis Research & Therapy|September 11, 2020
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trialsClara Malattia, Nicolino Ruperto, Silvia Pederzoli, et al.
Pageof 23